Shortage Avoided

ATRIANCE

NOVARTIS PHARMACEUTICALS CANADA INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of ATRIANCE in Canada?

Not currently. The most recent shortage report for ATRIANCE 5MG is marked resolved (last updated August 28, 2018).

Can I still get this?Check with your pharmacist

StatusShortage Avoided

Same-ingredient products on fileNone found

Affected strength5MG

Last updated2018-08-28

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

DIN

02299925

Strength

5MG

Dosage Form

SOLUTION

Route

INTRAVENOUS

Active Ingredient

NELARABINE

Tier

Unrated

Last Updated

2018-08-28

Reason for Shortage

Demand increase for the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from NOVARTIS PHARMACEUTICALS CANADA INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

2.5MG · DIN 02369257

10MG · DIN 02339528

5MG · DIN 02339501

7.5MG · DIN 02450267

2MG · DIN 02425645

5MG · DIN 02425661